Plasminogen activator inhibitor-1 is involved in impaired bone repair associated with diabetes in female mice

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Mao, Li ^a   Kawao, Naoyuki ^a   Tamura, Yukinori ^a   Okumoto, Katsumi ^b   Okada, Kiyotaka ^a   Yano, Masato ^a   Matsuo, Osamu ^a   Kaji, Hiroshi ^a  

^a KINKI UNIVERSITY   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 2; MESSENGER RNA; OSTEOCALCIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSCRIPTION FACTOR OSTERIX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE REMODELING; CARTILAGE MATRIX; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; FEMUR; HISTOPATHOLOGY; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ADIPOGENESIS; ANIMALS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY WEIGHT; BONE AND BONES; BONE RESORPTION; CHONDROGENESIS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; FEMALE; FEMUR; GENE EXPRESSION; MICE; MICE, KNOCKOUT; OSTEOCLASTS; OSTEOGENESIS; PLASMINOGEN ACTIVATOR INHIBITOR 1; WOUND HEALING;

EID: 84898651934     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092686     Document Type: Article

References (36)

1. Janghorbani M, Van Dam RM, Willett WC, Hu FB (2007) Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 166: 495-505. (Pubitemid 47283633)
2. Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes - a meta-analysis. Osteoporos Int 18: 427-444.
3. Hofbauer LC, Brueck CC, Singh SK, Dobnig H (2007) Osteoporosis in patients with diabetes mellitus. J Bone Miner Res 22: 1317-1328. (Pubitemid 351339677)
4. Merlotti D, Gennari L, Dotta F, Lauro D, Nuti R (2010) Mechanisms of impaired bone strength in type 1 and 2 diabetes. Nutr Metab Cardiovasc Dis 20: 683-690.
5. Wongdee K, Charoenphandhu N (2011) Osteoporosis in diabetes mellitus: Possible cellular and molecular mechanisms. World J Diabetes 2: 41-48.
6. McCabe LR (2007) Understanding the pathology and mechanisms of type I diabetic bone loss. J Cell Biochem 102: 1343-1357.
7. Shin L, Peterson DA (2012) Impaired therapeutic capacity of autologous stem cells in a model of type 2 diabetes. Stem Cells Transl Med 1: 125-135.
8. Liao YF, Chen LL, Zeng TS, Li YM, Fan Y, et al. (2010) Number of circulating endothelial progenitor cells as a marker of vascular endothelial function for type 2 diabetes. Vasc Med 15: 279-285.
9. Shoji T, Koyama H, Morioka T, Tanaka S, Kizu A, et al. (2006) Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes. Diabetes 55: 2245-2255. (Pubitemid 44743621)
10. Lerman OZ, Galiano RD, Armour M, Levine JP, Gurtner GC (2003) Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am J Pathol 162: 303-312. (Pubitemid 36042012)
11. Fadini GP, Albiero M, Vigili de Kreutzenberg S, Boscaro E, Cappellari R, et al. (2013) Diabetes impairs stem cell and proangiogenic cell mobilization in humans. Diabetes Care 36: 943-949.
12. Simpson CM, Calori GM, Giannoudis PV (2012) Diabetes and fracture healing: the skeletal effects of diabetic drugs. Expert Opin Drug Saf 11: 215-220.
13. Kayal RA, Alblowi J, McKenzie E, Krothapalli N, Silkman L, et al. (2009) Diabetes causes the accelerated loss of cartilage during fracture repair which is reversed by insulin treatment. Bone 44: 357-363.
14. Kayal RA, Tsatsas D, Bauer MA, Allen B, Al-Sebaei MO, et al. (2007) Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity. J Bone Miner Res 22: 560-568. (Pubitemid 47457433)
15. Kayal RA, Siqueira M, Alblowi J, McLean J, Krothapalli N, et al. (2010) TNF-alpha mediates diabetes-enhanced chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis through FOXO1. J Bone Miner Res 25: 1604-1615.
16. Retzepi M, Donos N (2010) The effect of diabetes mellitus on osseous healing. Clin Oral Implants Res 21: 673-681.
17. Gandhi A, Beam HA, O'Connor JP, Parsons JR, Lin SS (2005) The effects of local insulin delivery on diabetic fracture healing. Bone 37: 482-490. (Pubitemid 41317321)
18. Mathieu P, Lemieux I, Despres JP (2010) Obesity, inflammation, and cardiovascular risk. Clin Pharmacol Ther 87: 407-416.
19. Ma LJ, Mao SL, Taylor KL, Kanjanabuch T, Guan Y, et al. (2004) Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes 53: 336-346. (Pubitemid 38174548)
20. Tamura Y, Kawao N, Okada K, Yano M, Okumoto K, et al. (2013) Plasminogen activator inhibitor-1 is involved in streptozotocin-induced bone loss in female mice. Diabetes 62: 3170-3179.
21. Declerck PJ, Gils A (2013) Three decades of research on plasminogen activator inhibitor-1: a multifaceted serpin. Semin Thromb Hemost 39: 356-364.
22. Daci E, Verstuyf A, Moermans K, Bouillon R, Carmeliet G (2000) Mice lacking the plasminogen activator inhibitor 1 are protected from trabecular bone loss induced by estrogen deficiency. J Bone Miner Res 15: 1510-1516. (Pubitemid 30484520)
23. Kawao N, Tamura Y, Okumoto K, Yano M, Okada K, et al. (2013) Plasminogen plays a crucial role in bone repair. J Bone Miner Res 28: 1561-1574.
24. Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, et al. (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28: 2-17.
25. Pannekoek H, Veerman H, Lambers H, Diergaarde P, Verweij CL, et al. (1986) Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family. EMBO J 5: 2539-2544.
26. Sprengers ED, Kluft C (1987) Plasminogen activator inhibitors. Blood 69: 381-387. (Pubitemid 17022002)
27. Allan EH, Martin TJ (1995) The plasminogen activator inhibitor system in bone cell function. Clin Orthop Relat Res: 54-63.
28. Daci E, Udagawa N, Martin TJ, Bouillon R, Carmeliet G (1999) The role of the plasminogen system in bone resorption in vitro. J Bone Miner Res 14: 946-952. (Pubitemid 29262889)
29. Lu H, Kraut D, Gerstenfeld LC, Graves DT (2003) Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation. Endocrinology 144: 346-352. (Pubitemid 36076124)
30. Stevens MM, George JH (2005) Exploring and engineering the cell surface interface. Science 310: 1135-1138. (Pubitemid 41681731)
31. Wang H, Zhang Y, Heuckeroth RO (2007) PAI-1 deficiency reduces liver fibrosis after bile duct ligation in mice through activation of tPA. FEBS Lett 581: 3098-3104. (Pubitemid 46899037)
32. Oh CK, Ariue B, Alban RF, Shaw B, Cho SH (2002) PAI-1 promotes extracellular matrix deposition in the airways of a murine asthma model. Biochem Biophys Res Commun 294: 1155-1160. (Pubitemid 34687171)
33. Krause MP, Moradi J, Nissar AA, Riddell MC, Hawke TJ (2011) Inhibition of plasminogen activator inhibitor-1 restores skeletal muscle regeneration in untreated type 1 diabetic mice. Diabetes 60: 1964-1972.
34. Claes L, Recknagel S, Ignatius A (2012) Fracture healing under healthy and inflammatory conditions. Nat Rev Rheumatol 8: 133-143.
35. Rundle CH, Wang X, Wergedal JE, Mohan S, Lau KH (2008) Fracture healing in mice deficient in plasminogen activator inhibitor-1. Calcif Tissue Int 83: 276-284.
36. Rosen CJ, Ackert-Bicknell C, Rodriguez JP, Pino AM (2009) Marrow fat and the bone microenvironment: developmental, functional, and pathological implications. Crit Rev Eukaryot Gene Expr 19: 109-124.